MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Biosimilar Pharmaceuticals »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Biopsy, Needle < Biosimilar Pharmaceuticals < Biotechnology  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000324 (2019) Piercarlo Sarzi-Puttini [Italie] ; Angela Ceribelli [Italie] ; Daniela Marotto [Italie] ; Alberto Batticciotto [Italie] ; Fabiola Atzeni [Italie]Systemic rheumatic diseases: From biological agents to small molecules.
000357 (2019) Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000713 (2018) I. Serio [Italie] ; F. Tovoli [Italie]Rheumatoid arthritis: new monoclonal antibodies.
000871 (2018) Lucía Jiménez-Pichardo [Espagne] ; Rocío Gázquez-Pérez [Espagne] ; Jesús Francisco Sierra-Sánchez [Espagne]Degree of prescriber's knowledge about variability in biological drugs "innovators" in manufacturing process.
000A92 (2017) Shiwei Miao [République populaire de Chine] ; Li Fan [République populaire de Chine] ; Liang Zhao [République populaire de Chine] ; Ding Ding [République populaire de Chine] ; Xiaohui Liu [République populaire de Chine] ; Haibin Wang [République populaire de Chine] ; Wen-Song Tan [République populaire de Chine]Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab.
000B38 (2017) Mohammed I. Aladul [Royaume-Uni] ; Raymond W. Fitzpatrick [Royaume-Uni] ; Stephen R. Chapman [Royaume-Uni]Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK.
000D25 (2016) Ashley M. Hopkins [Australie] ; Susanna M. Proudman ; Agnes I. Vitry ; Michael J. Sorich ; Leslie G. Cleland ; Michael D. WieseTen years of publicly funded biological disease-modifying antirheumatic drugs in Australia.
001369 (2014) Petra Baji [Hongrie] ; Márta Péntek ; Lászl Czirják ; Zoltán Szekanecz ; György Nagy ; Lászl Gulácsi ; Valentin BrodszkyEfficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.
001421 (2014) Jorge Enrique Machado-Alba [Colombie] ; Andrés Felipe Ruiz [Colombie] ; Manuel Enrique Machado-Duque [Colombie]Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
001D50 (????) Thasia G. Woodworth [États-Unis] ; Alfons A. Den Broeder [Pays-Bas]Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Biosimilar Pharmaceuticals" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Biosimilar Pharmaceuticals" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Biosimilar Pharmaceuticals
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021